![]() |
| • | Revenue of $760 million, a 4% increase compared to the prior quarter and a 3% increase compared to the prior year |
| • | Loss from operations of $41 million; Net loss attributable to Tronox of $103 million including $15 million of restructuring and other charges, net of taxes, primarily associated with the closure of the Company’s Botlek and Fuzhou pigment plants; Adjusted net loss attributable to Tronox was $88 million (non-GAAP) |
| • | GAAP diluted loss per share was $0.65; Adjusted diluted loss per share was $0.55 (non-GAAP) |
| • | Adjusted EBITDA of $62 million; Adjusted EBITDA margin of 8.2% (non-GAAP) |
| • | Capital expenditures of $67 million in the quarter |
| • | Expect free cash flow to be positive in Q2 2026, largely offsetting Q1 cash use; Expect to deliver meaningful positive free cash flow for full year 2026 |
| • | Expect Q2 2026 TiO2 volumes to increase sequentially in the high single-digit percentage range |
| • | Expect Q2 2026 zircon volume levels to moderate slightly compared to Q1 |
| • | TiO2 and zircon Q2 2026 volumes could be higher, depending on regional inventory availability |
| • | TiO2 and zircon pricing both expected to improve sequentially in the mid-single-digit percentage range in Q2 2026 as a result of announced price increases and cost input-related surcharges |
| • | Q2 2026 Adjusted EBITDA expected to be $65-$85 million |
| ($M unless otherwise noted) | Q1 2026 | Q1 2025 | Y-o-Y%∆ | | Q4 2025 | Q-o-Q%∆ | | |||||||||||||
| Revenue | $ | 760 | $ | 738 | 3 | % | $ | 730 | 4 | % | ||||||||||
| TiO2 | $ | 616 | $ | 584 | 5 | % | $ | 577 | 7 | % | ||||||||||
| Zircon | $ | 89 | $ | 69 | 29 | % | $ | 78 | 14 | % | ||||||||||
| Other products | $ | 55 | $ | 85 | (35 | )% | $ | 75 | (27 | )% | ||||||||||
| (Loss) from operations | $ | (41 | ) | $ | (61 | ) | n/ | m | $ | (114 | ) | n/ | m | |||||||
| Net (loss) attributable to Tronox | $ | (103 | ) | $ | (111 | ) | n/ | m | $ | (176 | ) | n/ | m | |||||||
| GAAP diluted (loss) per share | $ | (0.65 | ) | $ | (0.70 | ) | n/ | m | $ | (1.11 | ) | n/ | m | |||||||
| Adjusted diluted (loss) per share | $ | (0.55 | ) | $ | (0.15 | ) | n/ | m | $ | (0.60 | ) | n/ | m | |||||||
| Adjusted EBITDA | $ | 62 | $ | 112 | (45 | )% | $ | 57 | 9 | % | ||||||||||
| Adjusted EBITDA Margin % | 8.2 | % | 15.2 | % | (700 | )bps | 7.8 | % | 40 | bps | ||||||||||
| Free cash flow | $ | (135 | ) | $ | (142 | ) | n/ | m | $ | 53 | n/ | m | ||||||||
| Y-o-Y % ∆ | Q-o-Q % ∆ | |||||
| Volume | Price / Mix | FX | Volume | Price / Mix | FX | |
| TiO2 | 5 % | (4)% | 4 % | 4 % | 3 % | 0 % |
| Zircon | 57 % | (28)% | — % | 14 % | 0 % | — % |
| Three Months Ended March 31, | ||||||||
| 2026 | 2025 | |||||||
| Net sales | $ | 760 | $ | 738 | ||||
| Cost of goods sold | 716 | 639 | ||||||
| Gross profit | 44 | 99 | ||||||
| Restructuring and other charges | 14 | 86 | ||||||
| Selling, general and administrative expenses | 71 | 74 | ||||||
| Loss from operations | (41 | ) | (61 | ) | ||||
| Interest expense | (53 | ) | (42 | ) | ||||
| Interest income | 2 | 2 | ||||||
| Loss on extinguishment of debt | — | — | ||||||
| Other expense, net | (12 | ) | (5 | ) | ||||
| Loss before income taxes | (104 | ) | (106 | ) | ||||
| Income tax provision | — | (5 | ) | |||||
| Net loss | (104 | ) | (111 | ) | ||||
| Net loss attributable to noncontrolling interest | (1 | ) | — | |||||
| Net loss attributable to Tronox Holdings plc | $ | (103 | ) | $ | (111 | ) | ||
| Loss per share: | ||||||||
| Basic | $ | (0.65 | ) | $ | (0.70 | ) | ||
| Diluted | $ | (0.65 | ) | $ | (0.70 | ) | ||
| Weighted average shares outstanding, basic (in thousands) | 158,889 | 158,138 | ||||||
| Weighted average shares outstanding, diluted (in thousands) | 158,889 | 158,138 | ||||||
| Other Operating Data: | ||||||||
| Capital expenditures | 67 | 110 | ||||||
| Depreciation, depletion and amortization expense | 75 | 71 | ||||||
| Three Months Ended March 31, | ||||||||
| 2026 | 2025 | |||||||
| Net loss attributable to Tronox Holdings plc (U.S. GAAP) | $ | (103 | ) | $ | (111 | ) | ||
| Restructuring and other charges (a) | 14 | 86 | ||||||
| Other (b) | 1 | 1 | ||||||
| Adjusted net loss attributable to Tronox Holdings plc (non-U.S. GAAP) | $ | (88 | ) | $ | (24 | ) | ||
| Diluted net loss per share (U.S. GAAP) | $ | (0.65 | ) | $ | (0.70 | ) | ||
| Restructuring and other charges, per share | 0.09 | 0.54 | ||||||
| Other, per share | 0.01 | 0.01 | ||||||
| Diluted adjusted net loss per share attributable to Tronox Holdings plc (non-U.S. GAAP) (1) | $ | (0.55 | ) | $ | (0.15 | ) | ||
| Weighted average shares outstanding, diluted (in thousands) | 158,889 | 158,138 | ||||||
| | March 31, 2026 | December 31, 2025 | ||||||
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash and cash equivalents | $ | 126 | $ | 199 | ||||
| Restricted cash | 12 | 12 | ||||||
| Accounts receivable (net of allowance for credit losses of $1 and $1 as of March 31, 2026 and December 31, 2025, respectively) | 331 | 289 | ||||||
| Inventories, net | 1,577 | 1,652 | ||||||
| Prepaid and other assets | 119 | 112 | ||||||
| Income taxes receivable | 1 | 1 | ||||||
| Total current assets | 2,166 | 2,265 | ||||||
| Noncurrent Assets | ||||||||
| Property, plant and equipment, net | 1,973 | 2,007 | ||||||
| Mineral leaseholds, net | 594 | 608 | ||||||
| Intangible assets, net | 208 | 214 | ||||||
| Lease right of use assets, net | 169 | 173 | ||||||
| Deferred tax assets | 834 | 833 | ||||||
| Other long-term assets | 113 | 117 | ||||||
| Total assets | $ | 6,057 | $ | 6,217 | ||||
| LIABILITIES AND EQUITY | ||||||||
| Current Liabilities | ||||||||
| Accounts payable | $ | 419 | $ | 481 | ||||
| Accrued liabilities | 231 | 274 | ||||||
| Short-term lease liabilities | 22 | 22 | ||||||
| Obligations under inventory financing arrangement | 50 | 50 | ||||||
| Short-term debt | 133 | 51 | ||||||
| Long-term debt due within one year | 39 | 39 | ||||||
| Income taxes payable | 1 | 2 | ||||||
| Total current liabilities | 895 | 919 | ||||||
| Noncurrent Liabilities | ||||||||
| Long-term debt, net | 3,124 | 3,132 | ||||||
| Pension and postretirement healthcare benefits | 80 | 81 | ||||||
| Asset retirement obligations | 207 | 198 | ||||||
| Environmental liabilities | 39 | 39 | ||||||
| Long-term lease liabilities | 146 | 148 | ||||||
| Deferred tax liabilities | 204 | 208 | ||||||
| Other long-term liabilities | 41 | 43 | ||||||
| Total liabilities | 4,736 | 4,768 | ||||||
| Commitments and Contingencies | ||||||||
| Shareholders’ Equity | ||||||||
| Tronox Holdings plc ordinary shares, par value $0.01 — 159,518,772 shares issued and outstanding at March 31, 2026 and 158,557,858 shares issued and outstanding at December 31, 2025 | 2 | 2 | ||||||
| Capital in excess of par value | 2,101 | 2,103 | ||||||
| (Accumulated deficit) retained earnings | (73 | ) | 30 | |||||
| Accumulated other comprehensive loss | (741 | ) | (717 | ) | ||||
| Total Tronox Holdings plc shareholders’ equity | 1,289 | 1,418 | ||||||
| Noncontrolling interest | 32 | 31 | ||||||
| Total equity | 1,321 | 1,449 | ||||||
| Total liabilities and equity | $ | 6,057 | $ | 6,217 | ||||
| Three Months Ended March 31, | ||||||||
| 2026 | 2025 | |||||||
| Cash Flows from Operating Activities: | ||||||||
| Net loss | $ | (104 | ) | $ | (111 | ) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
| Depreciation, depletion and amortization | 75 | 71 | ||||||
| Deferred income taxes | - | 4 | ||||||
| Share-based compensation expense | 6 | 5 | ||||||
| Amortization of deferred debt issuance costs and discount on debt | 3 | 2 | ||||||
| Restructuring and other charges | 14 | 86 | ||||||
| Other non-cash items affecting net loss | 16 | 12 | ||||||
| Changes in assets and liabilities: | ||||||||
| Increase in accounts receivable, net of allowance for credit losses | (43 | ) | (49 | ) | ||||
| Decrease (increase) in inventories, net | 67 | (35 | ) | |||||
| Decrease in prepaid and other assets | 5 | 18 | ||||||
| Restructuring payments | (19 | ) | (2 | ) | ||||
| Decrease in accounts payable and accrued liabilities | (80 | ) | (22 | ) | ||||
| Net changes in income tax payables and receivables | - | (4 | ) | |||||
| Changes in other non-current assets and liabilities | (8 | ) | (7 | ) | ||||
| Cash used in operating activities | (68 | ) | (32 | ) | ||||
| Cash Flows from Investing Activities: | ||||||||
| Capital expenditures | (67 | ) | (110 | ) | ||||
| Loans | - | 15 | ||||||
| Cash used in investing activities | (67 | ) | (95 | ) | ||||
| Cash Flows from Financing Activities: | ||||||||
| Repayments of short-term debt | (97 | ) | (6 | ) | ||||
| Repayments of long-term debt | (8 | ) | (6 | ) | ||||
| Repayments of inventory financing arrangement | (50 | ) | - | |||||
| Proceeds from short-term debt | 182 | 121 | ||||||
| Proceeds from inventory financing arrangement | 50 | - | ||||||
| Debt issuance costs | (2 | ) | - | |||||
| Dividends paid | (8 | ) | - | |||||
| Restricted stock and performance-based shares settled in cash for withholding taxes | - | (1 | ) | |||||
| Cash provided by financing activities | 67 | 108 | ||||||
| Effects of exchange rate changes on cash and cash equivalents and restricted cash | (5 | ) | 5 | |||||
| Net decrease in cash and cash equivalents and restricted cash | (73 | ) | (14 | ) | ||||
| Cash and cash equivalents and restricted cash at beginning of period | 211 | 152 | ||||||
| Cash and cash equivalents and restricted cash at end of period | $ | 138 | $ | 138 | ||||
| Three Months Ended March 31, | ||||||||
| 2026 | 2025 | |||||||
| Net loss (U.S. GAAP) | $ | (104 | ) | $ | (111 | ) | ||
| Interest expense | 53 | 42 | ||||||
| Interest income | (2 | ) | (2 | ) | ||||
| Income tax provision | — | 5 | ||||||
| Depreciation, depletion and amortization expense | 75 | 71 | ||||||
| EBITDA (non-U.S. GAAP) | 22 | 5 | ||||||
| Share-based compensation (a) | 6 | 5 | ||||||
| Accretion expense and other adjustments to asset retirement obligations and environmental liabilities (b) | 4 | 7 | ||||||
| Accounts receivable securitization program (c) | 3 | 4 | ||||||
| Foreign currency remeasurement (d) | 7 | 1 | ||||||
| Restructuring and other charges (e) | 14 | 86 | ||||||
| Other items (f) | 6 | 4 | ||||||
| Adjusted EBITDA (non-U.S. GAAP) | $ | 62 | $ | 112 | ||||
| Three Months Ended March 31, | ||||||||
| 2026 | 2025 | |||||||
| Net sales | $ | 760 | $ | 738 | ||||
| Net loss (U.S. GAAP) | $ | (104 | ) | $ | (111 | ) | ||
| Net loss (U.S. GAAP) as a % of Net sales | (13.7 | )% | (15.0 | )% | ||||
| Adjusted EBITDA (non-U.S. GAAP) (see above) as a % of Net sales | 8.2 | % | 15.2 | % | ||||
| March 31, 2026 | December 31, 2025 | |||||||
| Long-term debt, net | $ | 3,124 | $ | 3,132 | ||||
| Short-term debt | 133 | 51 | ||||||
| Long-term debt due within one year | 39 | 39 | ||||||
| (Less) Cash and cash equivalents | (126 | ) | (199 | ) | ||||
| Net debt | $ | 3,170 | $ | 3,023 | ||||
| Trailing-twelve month Adjusted EBITDA (non-U.S. GAAP) | $ | 286 | $ | 336 | ||||
| Net debt to trailing-twelve month Adjusted EBITDA (non-U.S. GAAP) (see above) | 11.1 | x | 9.0 | x | ||||
| Three Months Ended March 31, 2026 | ||||
| Cash used in operating activities | $ | (68 | ) | |
| Capital expenditures | (67 | ) | ||
| Free cash flow (non-U.S. GAAP) | $ | (135 | ) | |
| Three Months Ended | Trailing Twelve Month Adjusted EBITDA | |||||||||||||||||||
| June 30, 2025 | September 30, 2025 | December 31, 2025 | March 31, 2026 | |||||||||||||||||
| Net loss (U.S. GAAP) | $ | (85 | ) | $ | (100 | ) | $ | (177 | ) | $ | (104 | ) | $ | (466 | ) | |||||
| Interest expense | 45 | 48 | 54 | 53 | 200 | |||||||||||||||
| Interest income | (1 | ) | (1 | ) | (2 | ) | (2 | ) | (6 | ) | ||||||||||
| Income tax provision | 4 | 8 | (2 | ) | — | 10 | ||||||||||||||
| Depreciation, depletion and amortization expense | 74 | 75 | 82 | 75 | 306 | |||||||||||||||
| EBITDA (non-U.S. GAAP) | 37 | 30 | (45 | ) | 22 | 44 | ||||||||||||||
| Share-based compensation (a) | 4 | 5 | 6 | 6 | 21 | |||||||||||||||
| Foreign currency remeasurement (b) | (2 | ) | — | 7 | 7 | 12 | ||||||||||||||
| Accretion expense and other adjustments to asset retirement obligations and environmental liabilities (c) | 7 | 6 | (11 | ) | 4 | 6 | ||||||||||||||
| Accounts receivable securitization program (d) | 3 | 3 | 3 | 3 | 12 | |||||||||||||||
| Restructuring and other charges (e) | 42 | 25 | 79 | 14 | 160 | |||||||||||||||
| Other items (f) | 2 | 5 | 18 | 6 | 31 | |||||||||||||||
| Adjusted EBITDA (non-U.S. GAAP) | $ | 93 | $ | 74 | $ | 57 | $ | 62 | $ | 286 | ||||||||||
| 15 | Page |
